Biochemistry Orthim 3 Ferrum Phosphoricum D 12 Tablets, 400 pcs

Upute za korištenje Biochemistry Orthim 3 Ferrum Phosphoricum D 12 Tablets, 400 pcs

Important notes (compulsory information):

Biochemistry Orthim No. 3 Ferrum Phosphoricum DL2 tablets. Applications: Registered Homeopathic Medicine, therefore without specifying a therapeutic indication.

For risks and side effects, read the package leaflet and ask your doctor or pharmacist.


LEAFLET: INFORMATION FOR THE USER

Biochemistry Orthim No. 3 Ferrum Phosphoricum DL2 tablets
Biochemistry after Dr. Cheetler
Homeopathic medicine

Dear Patient, Please read this information information carefully because it contains important information about what you should consider when using this medicine. For questions, please contact your doctor or pharmacist.

Dosage form:
Tablets to take.

Registered homeopathic medicine, therefore without specifying a therapeutic indication. In the case of disease symptoms constant during the application of this medicine, medical advice must be obtained.

This leaflet contains:

1. What is no. 3 Ferrum phosphoricum D12 tablets and what is it used for?
2. What do you need before taking No. 3 Ferrum Phosphoricum D12 Tablets Note?
3. HOW IS NO. 3 Ferrum Phosphoricum D12 Tablets take?
4. WHAT SIDE EFFECTS ARE POSSIBLE?
5. HOW IS NO. 3 Ferrum Phosphoricum D12 Tablets Store?
6. ADDITIONAL INFORMATION

1. What is no. 3 Ferrum phosphoricum D12 tablets and what is it used for?

No. 3 Ferrum Phosphoricum D12 tablets is a homeopathic medicine.

2. What do you need before taking No. 3 Ferrum Phosphoricum D12 Tablets Note?

This medicine contains lactose:
In the case of known intolerance to certain sugars, no. 3 Ferrum Phosphoricum D12 tablets only take on medical consultation.

Pregnancy and breast feeding period:
Since there are no sufficiently documented experiences with pregnancy and lactation, an application should only be carried out after medical consultation.

When taking No. 3 Ferrum Phosphoricum D12 tablets with other medicines:
No interactions are known in the simultaneous use with other medicines. General Note: The effect of a homeopathic drug can be unfavorably influenced by generally damaging factors in the way of life and stimulus and enjoyment. If you take other medicines, please ask your doctor.

3. What is NO. 3 Ferrum Phosphoricum D12 Tablets take?

Always take # 3 Ferrum Phosphoricum D12 tablets exactly as directed in this leaflet. Please ask your doctor or pharmacist if you are not sure. An application beyond a week should only be done after consultation with a homeopathic experienced therapist. When improving the complaints, the frequency of taking is reduced.

4. Which side effects are possible?

There are no known side effects. Note: When taking a homeopathic medicinal product, existing complaints may be temporarily worn out (initial worstization). In this case, you should discontinue the medicine and consult your doctor. If you watch side effects, please tell your doctor or pharmacist.

5. What's NO. 3 Ferrum Phosphoricum D12 Tablets Store?

Store drug out of reach of children. Close packages after removal again. The medicine should be kept, especially after breaking, on a cool, dry place (e.g., in the bedroom). Note on durability: The medicine is no longer applied after the expiry of the expiry date specified on the container and the external enclosure. After opening, use within 12 months.

6. Further information

What No. 3 Ferrum Phosphoricum D12 tablets contains:
As a pharmaceutical agent is in a tableten: ferrum phosphoricum trit. D12 250 mg other ingredients are: Potato starch, Calciumbenat (DAB). No. 3 Ferrum Phosphoricum D12 tablets is gluten-free.

As No. 3 Ferrum Phosphoricum D12 tablets in the trade comes:
No. 3 Ferrum Phosphoricum D12 Tablets is 100 packages (N1) and 400 (N3) tablets available in pharmacies.

Pharmaceutical entrepreneur and manufacturer:
Orthim Kg
Otto-Hahn-Str. 17-19
33442 Herzebrock Clarwood
Tel.:+49 (0) 52 45/92 010-0
E-mail: [email protected]
www.orthim.com

Status of Information: November 2015.

Source: Information of the leaflet
Status: 04/2017